ASH: Venetoclax, Acalabrutinib Active in Relapsed CLL
Two studies show beneficial effects for patients with relapsed chronic lymphocytic leukemia
ASH: Prasugrel Doesn’t Cut Vaso-Occlusive Crisis in Sickle Cell
Rate of vaso-occlusive crisis events is not lower for children receiving prasugrel versus placebo
ADT for Prostate CA Tied to Increased Alzheimer’s Risk
Research suggests dose-dependent effect
Med Ed Can Be Improved for High-Value, Cost-Conscious Care
Review shows knowledge transmission, reflective practice, supportive environment aid learning
CDC: Fewer Americans Struggling With Medical Bills
U.S. report shows 12 million are no longer in families having trouble paying for health care
FDA Approves Vonvendi to Treat von Willebrand Disease
Approved for the as-needed treatment and control of bleeding episodes in adults
Guidelines Developed for Perinatal Hematologic Cancers
Diagnostic procedures, chemotherapy and radiotherapy, maternal supportive care discussed
Variation in Prices of Cancer Drugs in High-Income Countries
Difference in drug price between highest-, lowest-priced countries varies between 28 and 388 percent
ASH: Longer Red Blood Cell Unit Storage Noninferior
Longer-storage RBC units non-inferior for children with lactic acidosis due to anemia
ASH: Ibrutinib Bests Chlorambucil in Chronic Lymphocytic Leukemia
Improvements in progression-free survival, overall survival, response rate for ibrutinib
